Biological Oncology

Talvey

Payments companies reported to CMS as associated with Talvey. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$1.6Massociated payments (2023-2025)

9,661clinicians with associated payments

6companies reporting

By year

2023 $60K

2024 $621K

2025 $917K

Payments reported as associated with Talvey, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Hematology & Oncology $595K

Hematology (Internal Medicine) $175K

Medical Oncology $147K

Nurse Practitioner $139K

Family $139K

Physician Assistant $73K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Talvey

These are the largest totals companies reported as associated with Talvey. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Alexis Cruz Chacon	San Juan, PR	Hematology & Oncology	$36,753.41
Freddy Mendez Torres	Cayey, PR	Urology	$27,694.54
Surbhi Sidana	Stanford, CA	Hematology (Internal Medicine)	$26,101.22
Rafael Fonseca	Scottsdale, AZ	Hematology (Internal Medicine)	$25,273.19
Donna Catamero	New York, NY	Adult Health (Nurse Practitioner)	$22,590.94
Rahul Banerjee	Seattle, WA	Hematology & Oncology	$22,183.65
Ajai Chari	New York, NY	Hematology & Oncology	$18,092.55
Hans Lee	Houston, TX	Internal Medicine	$16,694.01
Beth Faiman	Cleveland, OH	Nurse Practitioner	$15,831.10
Binod Dhakal	Milwaukee, WI	Hematology & Oncology	$14,271.79

Prescribed Talvey?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.